In the present study, we investigate the in vitro antimicrobial activity of macrolides,~-lactams and tetracycline against Borrelia burgdorferi s.l. clinical and tick isolates. Minimal inhibitory concentrations (MICs) were determined in normal growth condition and after pre-exposure of the strains to sub-MIC of the founder of each drug family. All the classes of tested antibiotics showed good antibacterial activity against all the borreliae isolates and there were no significant susceptibility differences among clinical and tick isolates. After pre-exposure of the strains to sub-MIC of erythromycin, cefoxitin and tetracycline, we observed that some strains of B. burgdorferi s.l. showed higher MIC values to both the pre-exposed drug and drugs of the same family. The less susceptibility of borreliae, in the last growth condition in vitro, could be one of the justifications of clinical results indicating the limited efficacy of these antibiotics in treatment of B. burgdoferi infections.
Lyme borreliosis (LB), caused by Borrelia burgdorferi sensu lato, is the most common tickborne disease in the United States and Europe. LB is a multi-system disorder characterized by a skin lesion, the "Erythema Migrans" (EM), which can be followed, weeks or months later, by neurological, cardiac or arthritic manifestations (I). Several different genospecies of B. burgdorferi s.l. are known as pathogenic for humans. All the main three pathogenic genospecies, Borrelia burgdorferi sensu stricto, Borrelia garinii, and Borrelia afzelii occur in Italy (2-5). All patients with Lyme borreliosis should be treated with antibiotics to prevent possible progression of the disease (6) .
The aim of this work is: a) to investigate in vitro in B. burgdorferi s.l. isolates antimicrobial activity of some macrolides, p-lactams and tetracycline; b) to evidence whether in vitro pre-exposure of strains to sub-MIC of the tested drugs can change the MIC values towards each one.
MATERIALS AND METHODS

Spirochaetes
B. burgdorferi s.l. strains were obtained from the Istituto Superiore di Sanita culture collection. The strains included twelve clinical isolates obtained from patients of the "San Martino" Hospital of Belluno in Veneto: 11 of B. afzelii and one ofB. garinii, and 6 strains isolated from Ixodes ricinus ticks, 3 collected in the bordering area of Alto Adige-South Tyrol and Belluno and 3 collected in Switzerland (Neuchatel area) (7) (8) (9) .
The isolates were grown in Barbour-Stoenner-Kelly (BSK) medium (Sigma Chemical Co., St. Louis, MO) supplemented with 6% rabbit serum (Sigma) at 34°C and were stored in 2.5 ml test tubes. Reference strain tested was B31 (B. burgdorferi s.s.).
.. Determination of minimal inhibitory concentrations (MICs)
Stock solutions of the following antibiotics: erythromycin (E) (Sigma-Aldrich Chern. Co), azithromycin (AZI) (Pfizer), clarithromycin (CLA) (Menarini Italia), ampicillin (AMP) (Pfizer), cefoperazone (CPZ) (Sigma-Aldrich Chern.Co), cefoxitin (CX) (MMD Italy-Pavia), cefuroxime (CFX), ceftriaxone (CTR) (Sigma-Aldrich Chern.Co) and tetracycline (TET) (Pfizer) were prepared in sterile saline (I mglml). The antimicrobial agents used were diluted in BSK medium and concentrations ranged from 4 to 0.001 ug/ml. Borrelia cultures were incubated for 72 hours at 34°C, and the inoculum was adjusted to 2.5x I0 7 borreliae/ml by Burker counting chamber combined with dark field microscopy (10) (11) .
In order to determine the minimal inhibitory concentrations (MIC s) and to value the sub-MIC for each drug which did not interfere with borreliae vitality, 15 III of each culture was inoculated into each well of a microtiter tray containing 150 III of BSK medium, yielding a final concentration of 105 borreliae 1m!. The plates were incubated for 72 hours at 34°C.
The MIC was defined as the lowest concentration of antibiotic at which no motile spirochetes were observed at dark field microscopy. The sub-MIC of each drug was Y2 or Y4 MIC value for each strain, which was defined as the concentration of drug at which no borreliae number was reduced, and vitality was observed.
Pre-exposure to antibiotics
To determine the effect of pre-exposure to the tested antibacterial drugs, some clinical isolates of B. burgdorferi s.l (BL47, BU3, BUI, BUO, BL29, BL25, BLl2, BLlI) and reference strain B31 were exposed to Y2, or Y4 MIC value of erythromycin, cefoxitin and tetracycline, chosen as representative members of each family of the drugs and considered as inducer substrates. The strains were preexposed for 72 hours at 34°C in BSK medium. The inoculum of Ix10 5 borreliae/ml of the wild-type strains (Sw) and of the pre-exposed strains (Spe) was tested for determination of MIC s against all antibiotics in examination, at concentrations ranging between 4 and 0.001 ug/ml, in BSK medium. The inoculum was used under mutation frequency, in both experimental conditions 
RESULTS
All classes of the tested antibiotics showed good antibacterial activity against all the borrelia isolates, and there were no significant susceptibility differences among clinical and tick isolates (Table I) . Moreover, no significant differences in MICs values were evidenced among various Borrelia species.
Of all the drugs tested, only one clinical isolate, Biafzelii BL33, showed higher MIC levels that ranged from 0.12 to 0.50 ug/ml. Moreover, the Biafzelii BL34 strain showed the lowest MICs values against all the tested drugs (Table I ). The macrolides, p-lactams and tetracycline pointed out similar activity with MIC gO that didn't exceed 0.12 /ly/ml. (Table II) .
After pre-exposure of the strains to sub-MIC of erythromycin, cefoxitin and tetracycline, we observed that some strains of B. burgdorJeri changed their MIC values both towards the preexposed drug and drugs of the same family (Table II) .
Comparing MIC values obtained in the two growth conditions, MIC gO values in the pre-exposed strains showed an activity range between two-and ten-fold higher than wild-type strains (Table II, III) . The reference strain B31, after pre-exposure, did not show any differences in the MIC values (Table III) .
DISCUSSION
In the present study, we investigate the in vitro antimicrobial activity of macrolides, p-lactams and tetracycline against B. burgdorferi s.l. clinical and tick isolates. The results obtained point out good antibacterial activity of the tested drugs in normal growth conditions of borreliae. In this investigation no significant differences in MICs were observed in the three borreliae species, in agreement with the results obtained by Baradaran-Dilmaghani et al (12) .
Studies of the in vitro susceptibility of B. burgdorJeri s.l. to penicillins, macrolides, tetracycline and some cephalosporins, have indicated that B. burgdorferi s.l. strains were usually highly susceptible to these antibiotics and our results were in accordance with literature data on the wild-type growth condition (11, 13) . Diversely, our results pointed out that in sub-MIC pre-exposure growth condition, clinical isolates showed higher MIC values towards the inducer drugs and towards those of the same family.
The lower susceptibility ofborreliae described in this last growth condition could be one ofthe reasons for clinical reports indicating the limited efficacy of these antibiotics in the treatment of borreliosis (14) , and it could be the key to investigate the justification ofthe non-correspondence between the data obtained in vitro and in vivo. In fact, our experimental model in vitro of pre-exposure could be comparable with the condition in vivo during a therapeutic treatmen, and it could be the cause of the unsuccessfulness of the antibacterial treatment. Indeed, the unsuccessful therapy is due to the survival of the pathogen in body compartments where the antibiotic is not able to reach killing concentrations (15) and to a possible pre-exposure of strains at sub MIC during therapeutic treatment that could induce a changing in the susceptibility of B. burgdorferi strains (16), as our experimental model showed. In the reference strain B31, we do not observe any increasing of MICs values; this result enhances the opinion that the selective pressure of the antibacterial drugs and the in vivo contact with the normal microbial flora are the reasons for acquired and spreading resistances.
Further studies will be directed to clarify the mechanisms of antimicrobial resistance in B. burgdorferi. In fact, as well as in Gram-positive and Gram-negative bacteria, antimicrobial resistance is regulated by inducible and constitutive genes, and we are studying similar behaviours in B. burgdorJeri to correlate their phenotype with their genotype.
